• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种测量血浆中凝血因子 VIII 水平方法的比较。

Comparison of three methods for measuring factor VIII levels in plasma.

作者信息

Chandler Wayne L, Ferrell Chris, Lee Joo, Tun Theingi, Kha Hien

机构信息

Dept of Laboratory Medicine, Box 357110, University of Washington, Seattle, WA 98195, USA.

出版信息

Am J Clin Pathol. 2003 Jul;120(1):34-9. doi: 10.1309/C8T8-YNB4-G3W4-5PRF.

DOI:10.1309/C8T8-YNB4-G3W4-5PRF
PMID:12866370
Abstract

We compared 1-stage clot-based, chromogenic, and immunoassay methods for measuring factor VIII in plasma with a focus on the measurement of elevated levels of factor VIII. The chromogenic assay showed the best interassay imprecision for factor VIII levels near 150 IU/dL. The best correlation was between the 1-stage clot-based and chromogenic factor VIII assays (r2 = 0.934), and the lowest correlation was between the 1-stage clot-based and antigenic factor VIII assays (r2 = 0.821). The presence of heparin, low-molecular-weight heparin, lepirudin, or lupus inhibitors in the sample resulted in major interference in the 1-stage clot-based assay but not the chromogenic or antigenic factor VIII assays. Overall, the chromogenic factor VIII activity assay was the optimal method, showing good precision, the best overall correlation with other assays, and no interference from heparin, low-molecular-weight heparin, lepirudin, or lupus inhibitors.

摘要

我们比较了用于测量血浆中凝血因子VIII的一步法凝血检测、发色底物法和免疫测定法,重点是对升高的凝血因子VIII水平的测量。发色底物法在凝血因子VIII水平接近150 IU/dL时显示出最佳的批间精密度。一步法凝血检测与发色底物法检测凝血因子VIII之间的相关性最佳(r2 = 0.934),而一步法凝血检测与抗原性凝血因子VIII检测之间的相关性最低(r2 = 0.821)。样本中存在肝素、低分子量肝素、水蛭素或狼疮抑制剂会对一步法凝血检测产生重大干扰,但不会干扰发色底物法或抗原性凝血因子VIII检测。总体而言,发色底物法凝血因子VIII活性检测是最佳方法,显示出良好的精密度,与其他检测方法的总体相关性最佳,并且不受肝素、低分子量肝素、水蛭素或狼疮抑制剂的干扰。

相似文献

1
Comparison of three methods for measuring factor VIII levels in plasma.三种测量血浆中凝血因子 VIII 水平方法的比较。
Am J Clin Pathol. 2003 Jul;120(1):34-9. doi: 10.1309/C8T8-YNB4-G3W4-5PRF.
2
Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
Thromb Haemost. 2000 Dec;84(6):942-8.
3
Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
Am J Vet Res. 1998 May;59(5):538-41.
4
Diagnosis of factor VIII deficiency.
Haemophilia. 2008 Jul;14 Suppl 3:76-82. doi: 10.1111/j.1365-2516.2008.01715.x.
5
Clinical application of a chromogenic substrate method for determination of factor VIII activity.一种用于测定因子VIII活性的显色底物法的临床应用。
Thromb Haemost. 1985 Dec 17;54(4):818-23.
6
[Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].[使用一步凝固法和发色底物法测定哺乳动物凝血因子 VIII 活性]
Berl Munch Tierarztl Wochenschr. 2002 Jul-Aug;115(7-8):297-302.
7
comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays.基于凝块的因子 Xa 促凝血磷脂活性测定与显色因子 Xa 促凝血磷脂活性测定的比较。
Am J Clin Pathol. 2012 Feb;137(2):185-92. doi: 10.1309/AJCPGSJ4NHFQMX9W.
8
A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates.
Thromb Haemost. 2001 Oct;86(4):1132-3.
9
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.体外循环期间高剂量肝素化监测——凝血酶原酶诱导凝血时间(PiCT)与两种发色底物法抗Xa因子活性测定的比较
Thromb Haemost. 2008 Feb;99(2):427-34. doi: 10.1160/TH07-04-0307.
10
A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants.
Thromb Haemost. 1998 Jan;79(1):237-8.

引用本文的文献

1
Diagnosis and laboratory monitoring of acquired hemophilia A.获得性血友病 A 的诊断和实验室监测。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):11-18. doi: 10.1182/hematology.2023000460.
2
The dos, don'ts, and nuances of thrombophilia testing.血栓形成倾向检测的注意事项。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):593-599. doi: 10.1182/hematology.2023000491.
3
Lupus Anticoagulant Detection under the Magnifying Glass.放大镜下的狼疮抗凝物检测
J Clin Med. 2023 Oct 20;12(20):6654. doi: 10.3390/jcm12206654.
4
Acquired Hemophilia A Masquerading as Bleeding on Anticoagulation: A Case Report Including Key Laboratory Considerations.伪装成抗凝治疗出血的获得性血友病A:一例报告及关键实验室检查要点
Cureus. 2023 Jun 27;15(6):e41029. doi: 10.7759/cureus.41029. eCollection 2023 Jun.
5
Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review.成人和儿童中因子VIII、IX和XI在静脉血栓形成复发风险中的作用:一项系统评价。
Res Pract Thromb Haemost. 2023 Feb 2;7(2):100064. doi: 10.1016/j.rpth.2023.100064. eCollection 2023 Feb.
6
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review.晚期黑色素瘤患者使用PD1/PDL1抑制剂后获得性血友病的诊断:两例患者的经验及文献综述
Diagnostics (Basel). 2022 Oct 21;12(10):2559. doi: 10.3390/diagnostics12102559.
7
Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.获得性血友病A:当前临床实践指南与经验
J Blood Med. 2022 May 11;13:255-265. doi: 10.2147/JBM.S284804. eCollection 2022.
8
Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report.双重抗凝治疗及狼疮抗凝物背景下获得性血友病A:一例报告
J Med Case Rep. 2022 May 3;16(1):177. doi: 10.1186/s13256-022-03402-x.
9
Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!是否应对所有患者凝血因子检测进行多因素稀释?让辩论开始吧!
Res Pract Thromb Haemost. 2022 Mar 13;6(2):e12689. doi: 10.1002/rth2.12689. eCollection 2022 Feb.
10
International recommendations on the diagnosis and treatment of acquired hemophilia A.国际上关于获得性血友病 A 的诊断和治疗建议。
Haematologica. 2020 Jul;105(7):1791-1801. doi: 10.3324/haematol.2019.230771. Epub 2020 May 7.